LifeStance Health Group, Inc. (LFST) 8-K Current Report: March 11, 2026
Filed: March 11, 2026
Health Care
Services-Health ServicesLifeStance Health Group, Inc. (LFST) 8-K current report filed with SEC EDGAR on March 11, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
LifeStance Health Group, Inc. 8-K Mar 11, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Lisa Miller promoted to COO effective March 10, 2026, previously EVP Practice Operations since Feb 2024 — internal promotion signals continuity
- • Annual base salary set at $485,000 with target bonus of 85% of base (~$412,250), implying total cash target ~$897,250
- • Annual equity award of ~$1,500,000 in RSUs (mix of time-based and performance-based), vesting over 3 years
- • Performance RSUs tied to achievement of undisclosed targets — alignment with operational execution critical for a behavioral health operator scaling clinician capacity
Other LifeStance Health Group, Inc. 8-K Filings
Get deeper insights on LifeStance Health Group, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.